logo
CONTENT TYPES

Figure 1Loading Img
RETURN TO ISSUEPREVResearch ArticleNEXT

Robust Anticancer Efficacy of a Biologically Synthesized Tumor Acidity-Responsive and Autophagy-Inducing Functional Beclin 1

View Author Information
Institute of Biotechnology, the Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institutes of Biomedical Sciences, and §School of Life Science, Shanxi University, Taiyuan 030006, China
CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China
*E-mail: [email protected] (G.-B.D.).
*E-mail: [email protected] (Z.L.).
*E-mail: [email protected] (G.N.).
Cite this: ACS Appl. Mater. Interfaces 2018, 10, 6, 5227–5239
Publication Date (Web):January 23, 2018
https://doi.org/10.1021/acsami.7b17454
Copyright © 2018 American Chemical Society
Article Views
670
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

Read OnlinePDF (5 MB)
Supporting Info (1)»

Abstract

Abstract Image

As a potent autophagy inducer, Beclin 1 is essential for the initiation of autophagic cell death, and triggering extensive autophagy by targeted delivery of Beclin 1 to tumors has enormous potential to inhibit tumor growth. Yet, the therapeutic application of Beclin 1 is hampered by its inability to internalize into cells and nonselective biodistribution in vivo. To tackle this challenge, we employed a novel Beclin 1 delivery manner by constructing a functional protein (Trx-pHLIP-Beclin 1, TpB) composed of a thioredoxin (Trx) tag, a pH low insertion peptide (pHLIP), and an evolutionarily conserved motif of Beclin 1. This protein could effectively transport Beclin 1 to breast and ovarian cancer cell lines under weakly acidic conditions (pH 6.5), markedly inhibit tumor cell growth and proliferation, and induce obvious autophagy. Furthermore, the in vivo antitumor efficacy of the functional Beclin 1 against an SKOV3 xenograft tumor mouse model was tested via intravenous injection. TpB preferentially accumulated in tumors and exhibited a significantly higher tumor growth inhibition than the nontargeted Beclin 1 control, whereas no overt side effects were observed. Taken together, this study sheds light on the potential application of TpB as a highly efficient yet safe antitumor agent for cancer treatment.

Supporting Information

ARTICLE SECTIONS
Jump To

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsami.7b17454.

  • Agarose gel electrophoresis (Figure S1); SDS-PAGE analysis of Trx (Figure S2); CD spectra of TpB (Figure S3); crystal violet staining assay (Figure S4); detection of the appearance of acidic vesicular organelles (Figure S5); p62 and LC3 expressions (Figure S6); level of Beclin 1 (Figure S7); immunostaining of excised tumors (Figure S8); MALDI-TOF analysis of Trx (Table S1); MALDI-TOF analysis of TpB (Table S2) (PDF)

Terms & Conditions

Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

Cited By


This article is cited by 8 publications.

  1. Huihui Zhang, Xiaojiao Zhu, Hong Li, Gang Liu, Junjun Wang, Aidong Wang, Lin Kong, Weiju Zhu, Hongping Zhou. A RNA-Targeted Two-Photon Bioprobe with High Selective Permeability into Nuclear Pore Complexes for Dynamically Tracking the Autophagy Process among Multi-Organelles. Analytical Chemistry 2019, 91 (23) , 14911-14919. https://doi.org/10.1021/acs.analchem.9b03009
  2. Dan Wang, Haiyan Lin, Guilong Zhang, Yuanchun Si, Hongyi Yang, Guo Bai, Chi Yang, Kai Zhong, Dongqing Cai, Zhengyan Wu, Renfei Wang, Duohong Zou. Effective pH-Activated Theranostic Platform for Synchronous Magnetic Resonance Imaging Diagnosis and Chemotherapy. ACS Applied Materials & Interfaces 2018, 10 (37) , 31114-31123. https://doi.org/10.1021/acsami.8b11408
  3. Victor Vasquez-Montes, Janessa Gerhart, Damien Thévenin, Alexey S. Ladokhin. Divalent Cations and Lipid Composition Modulate Membrane Insertion and Cancer-Targeting Action of pHLIP. Journal of Molecular Biology 2019, 431 (24) , 5004-5018. https://doi.org/10.1016/j.jmb.2019.10.016
  4. Dong Mei, Binlong Chen, Bing He, Haibin Liu, Zhiqiang Lin, Jialiang Lin, Xiaoyan Zhang, Ning Sun, Libo Zhao, Xiaoling Wang, Qiang Zhang. Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer. Acta Pharmaceutica Sinica B 2019, 9 (5) , 1061-1077. https://doi.org/10.1016/j.apsb.2019.03.006
  5. Rong Fu, Peng Yang, Zongwei Li, Wen Liu, Sajid Amin, Zhuoyu Li. Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3. Cell Death & Disease 2019, 10 (8) https://doi.org/10.1038/s41419-019-1825-5
  6. Zhengjie Zhou, Yang Yan, Li Wang, Qiang Zhang, Yiyun Cheng. Melanin-like nanoparticles decorated with an autophagy-inducing peptide for efficient targeted photothermal therapy. Biomaterials 2019, 203 , 63-72. https://doi.org/10.1016/j.biomaterials.2019.02.023
  7. Xuan Qin, Xiaodong Shi, Licheng Tu, Yue Ma, Ziyuan Zhou, Rongtong Zhao, Meimiao Zhan, Feng Yin, Zigang Li. Autophagy inducing cyclic peptides constructed by methionine alkylation. Chemical Communications 2019, 55 (29) , 4198-4201. https://doi.org/10.1039/C9CC01027K
  8. Wan Zhou, Shandong Ye. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy. Cell Biology International 2018, 42 (10) , 1282-1291. https://doi.org/10.1002/cbin.11015

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE